Your browser doesn't support javascript.
loading
Prognostic significance of immunohistochemical epithelial-mesenchymal transition markers in skin melanoma patients.
Pieniazek, Malgorzata; Donizy, Piotr; Halon, Agnieszka; Leskiewicz, Marek; Matkowski, Rafal.
Afiliación
  • Pieniazek M; Department of Clinical Oncology, Tadeusz Koszarowski Regional Oncology Center, Opole, Katowicka 66a, Poland.
  • Donizy P; Department of Pathomorphology & Oncological Cytology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.
  • Halon A; Department of Pathomorphology & Oncological Cytology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.
  • Leskiewicz M; Department of Statistics, Wroclaw University of Economics, Komandorska 118-120, 53-345 Wroclaw, Poland.
  • Matkowski R; Department of Oncology & Division of Surgical Oncology, Wroclaw Medical University, pl. Hirszfelda 12, 53-413 Wroclaw, Poland.
Biomark Med ; 10(9): 975-85, 2016 Sep.
Article en En | MEDLINE | ID: mdl-27586584
ABSTRACT

AIM:

To investigate secreted protein acidic and rich in cystein (SPARC) and neural cadherin (NCAD), which are associated with epithelial-mesenchymal transition in primary skin melanoma and nodal metastases and their prognostic impact in melanoma patients.

METHODS:

Expression of proteins was assessed by immunochemistry in archival paraffin samples from 103 primary melanoma tumors and 16 nodal metastases.

RESULTS:

Increased expression of SPARC and NCAD in primary skin melanoma was associated with decreased overall survival, adverse clinicopathological features and particularly with microsatellitosis (SPARC) and ulceration (NCAD). In univariate Cox regression analysis, both biomarkers were significantly associated with the risk of death; the multivariate Cox regression analysis identified no significance.

CONCLUSION:

The most important result of our study was that we confirmed the strict correlation between SPARC and NCAD expression and clinicopathological parameters related with melanoma progression, which is a specific clinical equivalent of the molecular mechanisms of epithelial-mesenchymal transition process and confirms its key role in the disease outcome.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Biomarcadores de Tumor / Melanoma Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biomark Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Polonia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Biomarcadores de Tumor / Melanoma Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biomark Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Polonia